کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3806380 1245291 2015 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Prescribing in liver disease
ترجمه فارسی عنوان
تجویز در بیماری کبد
کلمات کلیدی
داروهای هپاتوتوکسیک، بیماری کبد، فارماکودینامیک، فارماکوکینتیک، تجویز
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی و دندانپزشکی (عمومی)
چکیده انگلیسی

Patients with liver disease often require drug therapy. Since the liver is the main site of drug detoxification and elimination in the body, each patient's need for therapy must be carefully assessed; the choice of drug, its dose, and duration of therapy must be carefully considered in order to avoid adverse effects. Ideally, one should choose a drug that has a high therapeutic index, is largely devoid of pharmacokinetic and pharmacodynamic interactions and hepatotoxic effects, and is renally eliminated. However, the ideal drug with these properties is often not available, and in such cases the dose and drug should be individualized to the patient, who should then be carefully monitored, the duration of treatment being kept as short as possible. The British National Formulary contains useful information on drugs that should be avoided or their dosage modified in patients with liver disease.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Medicine - Volume 43, Issue 10, October 2015, Pages 577–580
نویسندگان
,